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Abstract The efficiency of membrane fusion between recon- 
stituted Sendai viral envelopes containing only the fusion protein 
(F-virosomes) and the plasma membrane of mouse teratocarci- 
noma cells (F9) in culture was assessed using an assay based on 
the relief of self-quenching of a lipid probe incorporated in the F- 
virosomes. The potential of F-virosomes was also evaluated for a 
targeted cytosolic delivery of lysozyme to F9 cells. [125I]Lyso- 
zyme entrapped into F-virosomes was taken to examine its 
fusion-mediated transfer to the F9 cells. Target specificity of the 
F-virosomes was confirmed by the interaction between the 
terminal Le x moiety (Gal~l --, 4(Fuc~l - ,  3)GIcNAe) of F 
protein and the Le x determinant on the membrane of F9 cells. 
Incubation of the loaded F-virosomes with cells led to fusion- 
mediated delivery, as inferred from the ability of cells to 
internalize lysozyme in the presence of azide (a potent inhibitor 
of endocytosis). These results suggest that carbohydrate- 
carbohydrate interaction is strong enough for target cell 
recognition followed by phospholipid bilayer melding induced 
by fusion glycoprotein of Sendai virus. 
glycoprotein containing biantennary chains with Le x determi- 
nants (Gall31 ~ 4(Fuced ~ 3)GlcNAc) in the outer chain moi- 
eties [7]. We have recently demonstrated that reconstituted 
Sendai viral envelopes containing the F protein (F-virosomes) 
can fuse and efficiently deliver entrapped aqueous markers to 
target cells in the presence of targeting ligand like lectins [8], 
or by virtue of terminal galactose-asialoglycoprotein r ceptor 
interaction in case of liver cells both in vitro [9,10] and in vivo 
[11]. In the present work, we have prepared F-virosomes con- 
taining a fluorescent lipid in its membrane or loaded with 
[125I]lysozyme. These virosome can efficiently fuse with F9 
cells, as exhibited by the lipid mixing assay, and microinject 
the encapsulated [125I]lysozyme in the cell cytoplasm by means 
of Le×-Le x interaction. The efficiency of F-virosome as a se- 
lective carrier of drugs to various Le×-bearing tumor cells is 
discussed. 
2. Materials and methods 
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I. Introduction 
Le x or CD15 determinant (cd--*3 fucosylated type 2 car- 
bohydrate chain) has been shown to function as an adhesion 
molecule capable of Ca2+-mediated homotypic binding [1]. 
Cells with high surface expression of Le x, like mouse terato- 
carcinoma cells, F9, therefore exhibit strong self-aggregation 
(based on LeX-Le x interaction) in the presence of Ca 2+ [2]. Le x 
and related structures are regarded as human tumor-asso- 
ciated carbohydrate antigens, being highly accumulated in 
various human tumors [3]. These structures have also been 
suggested to be involved in the activation of platelets by tu- 
mor cells which in turn is correlated with malignancy [4,5]. A 
monoclonal antibody against carbohydrate antigen Le y 
(a l  ~ 2 fucosylated erivative of LeX), chemically linked to 
a genetically engineered form of Pseudomonas exotoxin, has 
been recently demonstrated to have excellent anti-tumor ac- 
tivity against LeY-positive tumors [6]. The possibility of tar- 
geted anti-tumor chemotherapy using Le x as a ligand is rec- 
ognized widely. 
The fusion protein (F) of the Sendai viral envelope is a 
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Abbreviations: F, fusion factor; CHO, Chinese hamster ovary; 
DMEM, Dulbecco's modified Eagle's medium; DPBS, Dulbecco's 
phosphate-buffered saline; TX-100, Triton X-100; DTT, dithiothrei- 
tol; NBD-PE, N-4-nitrobenzo-2-oxa-l,3-diazole phosphatidylethanol- 
amine; FCS, fetal calf serum 
2.1. Reagents 
N-4-Nitrobenzo-2-oxa-l,3-diazole phosphatidylethanolamine 
(NBD-PE) was purchased from Avanti (Birmingham, AL). SM2 
Bio-Beads were obtained from Bio-Rad (Richmond, CA). Triton-X- 
100 (TX-100) was obtained from Aldrich (Milwaukee, WI). Lysozyme 
(chicken egg white, IUB No. 3.2.1.17), DTT, sodium azide and EDTA 
(disodium salt) were purchased from Sigma Chemical Co. (St. Louis, 
MO, USA). Dulbecco's modified Eagle's medium (DMEM), Dulbec- 
co's phosphate buffered saline (DPBS), fetal calf serum (FCS), tryp- 
sin-EDTA, penicillin-streptomycin were obtained from Gibco (Grand 
Island, NY, USA). Carrier-free Na125I was obtained from BARC, 
Bombay, India. All other reagents used were of analytical grade. 
2.2. Virus 
Sendai virus was isolated and its activity was determined as pre- 
viously described [8]. 
2.3. Cells 
Mouse teratocarcinoma F9 cells (from ATCC, Bethesda, MD, 
USA) were grown on gelatin-coated plates in DMEM containing 
4.5 g/1 glucose and supplemented with 10% FCS (v/v). The plates 
were prepared by incubating 0.01% gelatin in water for 2 h at 4°C 
followed by washing once with water. Chinese hamster ovary (CHO) 
cells (Le~-deficient) were grown at 37°C, 5% CO2 in DMEM. Single- 
cell suspensions of F9 and CHO cells were made by lifting them from 
monolayers with 10 mM EDTA in DPBS. The cells were then washed 
three times with DPBS containing 1mM CaC12 and 1 mM MgC12 and 
finally suspended in the same buffer. 
2.4. Radioiodination of lysozyme 
Lysozyme was radiolabeled with the chloramine-T method, using 
Na125I as the iodine source [12]. The labeled protein was separated 
from free iodine by gel filtration through a Sephadex G-25 column. 
The specific activity of the labeled protein was calculated from the 
TCA-precipitable counts and expressed as cpm/mg protein. 
2.5. Preparation of NBD-PE-labeled and loaded F-virosomes 
Reconstituted Sendai viral envelopes containing the F protein (F- 
virosomes) were prepared essentially as described by Bagai et al. [8]. 
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NBD-PE was incorporated into the virosomes as described earlier [8]. 
Briefly, the NBD-PE dissolved in chloroform was dried in a glass vial 
under nitrogen to form a thin film. The supernatant from the deter- 
gent extract of the virus, containing only the F protein and lipids, was 
added to the NBD-PE film and incubated at 200C for 30 min with 
gentle shaking. The detergent was removed by stepwise addition of 
SM2 Biobeads as described earlier [8]. Loaded F-virosomes containing 
[125I]lysozyme were prepared as described by Bagai and Sarkar [10]. 
The unentrapped protein was separated by repeated centrifugation at
100000 x g for 1 h at 4°C. Radioactivity associated with virosomes 
was estimated using 1275 Minigamma Counter (LKB, Wallac). SDS- 
PAGE was carried out to test the purity of F-virosomes. 
2.6. Spectrofluorometric measurements 
The fusion of NBD-PE labeled F-virosomes with F9 cells was car- 
ried out essentially as described earlier [8]. The virosomes (25 ~tg of 
protein) were mixed with 107 cells in 1 ml of DPBS containing 1 mM 
Ca 2+ and 1 mM Mg 2+ and incubated at 4°C for 40 min. The virosome 
cell complexes were washed three times at 300xg in the same buffer 
to remove unbound virosomes. This suspension was then incubated 
for various time points at 37°C. Fluorescence changes as a result of 
fusion of NBD-PE-labeled F-virosomes with F9 cells, at various time 
points, were measured with a spectrofluorometer (model RF 540, 
Shimadzu Corp., Kyoto, Japan). 100 I.tl of the virosome-F9 cell sus- 
pension (after various times of incubation at 37°C) was placed into a 
cuvette containing 3 ml DPBS and fluorescence measured at 560/590 
nm (excitation/emission) wavelength. The fluorescence dequenching 
(%FDQ) data were normalized and calculated according to the fol- 
lowing equation: %FDQ = 100 × (F--Fo/FT-Fo); where F and FT are 
the fluorescence (arbitrary) units at a given time point and in the 
presence of 0.1% TX-100, respectively, and F0 is the observed fluor- 
escence after incubation at 4°C. As controls, the binding and fusion 
assays were done in the presence of 10 mM sodium azide, or 50 mM 
EDTA in DPBS. As another control, heat-treated F-virosomes (incu- 
bated at 560C for 20 min) were used to study binding and fusion with 
F9 cells in the presence or absence of 10 mM sodium azide. To check 
the specificity of interaction, F-virosomes were incubated with CHO 
cells under similar conditions as those for F9 cells. 
2. 7. Fusion-mediated delivery of [125I]lysozyme into F9 cells 
Single-cell suspensions of F9 cells were made as described above 
and suspended in DPBS to obtain 2×106 cells/ml. Viability of the 
cells was checked by staining with Nigrosin [13]. Loaded F-virosomes 
(200 ~tg F protein in 0.2 ml DPBS with 1 mM Ca 2+ and 1 mM Mg 2+, 
containing 0.8-1 txg [125I]lysozyme, 5× 107 cprn/mg) were incubated 
with 1 ml F9 cells (2X106) in culture tubes for 40 min in ice. The 
virosome-cell mixtures were then washed with chilled DPBS thrice to 
remove unbound virosomes. The virosome-cell suspensions were then 
suspended in DPBS containing 1mM Ca 2+ and Mg 2+ and incubated 
at 37°C for 30 min. The cells were then pelleted at 1000xg for 10 min 
at 4°C and finally incubated for 10 min at 4°C in DPBS containing 50 
mM EDTA (stripping) to remove the cell surface bound (unfused) 
virosomes. The cell pellet after EDTA stripping was solubilized in 
the extraction buffer (10 mM Tris-C1, 150 mM NaC1, pH 7.4 contain- 
ing 1% TX-100 and 1 mM PMSF) and the cell associated radioactivity 
was determined. As control, binding and fusion was carried out using 
heat-treated F-virosomes. Sodium azide is known to be an efficient 
inhibitor of the endocytotic process [14]. Binding and fusion of F- 
virosomes and heat-treated F-virosomes with F9 cells were studied 
in the presence of 10 mM azide as described earlier [10]. 
2.8. Cell fractionation 
F-virosomes (untreated or heat-treated, 2 mg F protein in each 
case) were incubated with F9 cells (2× 107) at 37°C for 30 min. After 
washing three times with DPBS and EDTA stripping, the cells were 
subjected to subcellular fractionation following a published procedure 
[15]. In brief, the cells were resuspended in isotonic homogenizing 
buffer (0.01 M Tris.C1, pH 7.4 containing 0.25 M sucrose) and then 
dispersed in a Potter-Elvehjem type homogenizer at4°C. The isolation 
of nuclear, lysosomal/mitochondrial and plasma membrane fractions 
was carried out by differential centrifugation at600 x g, 15 000 x g and 
100000Xg at 4°C for 10, 30 and 60 min, respectively. Cytosolic frac- 
tion comprised the supernatant obtained after the final centrifugation 
(100 000 X g). Subcellular fractions were further characterized by mar- 
ker enzyme analysis [16]. Radioactivity associated with each fraction 
was analyzed and expressed as percent of total amount of radioactiv- 
ity associated with the whole cells. 
3. Results 
3.1. Fusion of  F-virosomes with F9 cells 
It has been shown earlier by our laboratory that F-viro-  
somes can b ind and fuse efficiently with HepG2 cells through 
the interact ion o f  the terminal  galactose of  F with the ASGP-  
R [8-10]. We used a similar system to analyze the binding and 
fusion o f  NBD-PE- labe led  F-v i rosomes with F9 cells by in- 
cubat ing the v i rosomes with F9 cells for 30 min at 37°C, 
taking b inding and fusion in the presence o f  10 mM sodium 
azide or 50 mM EDTA,  or taking heat- t reated F-v i rosomes,  
as controls.  Fig. 1 shows that F -v i rosomes fused efficiently 
with F9 cells even in the presence of  10 mM sodium azide 













0 L ~  
Fig. 1. Fusion of F-virosomes and heat-treated F-virosomes with F9 
cells via LeX-Le X interactions. NBD-PE-labeled F-virosomes (25 I.tg 
of protein) (untreated or heat-treated) were incubated at 4°C for 40 
rain with 107 F9 cells (or CHO cells) in 1 ml of DPBS containing 
either 1 mM Ca ~+ and 1 mM Mg 2+ (without or with 10 mM azide) 
or 50 mM EDTA. The virosome-cell complexes were washed three 
times at 300xg (4°C) in the same buffer to remove unbound viro- 
somes. 100 ~tl of the virosome-F9 cell suspension was placed into a 
cuvette containing 3 ml chilled PBS and fluorescence was measured 
at 560/590 nm (excitation/emission) wavelength with a spectrofluo- 
rometer (model RF 540, Shimadzu Corp., Kyoto, Japan). The rest 
of the suspension was incubated at 37°C for 30 min. Fluorescence 
changes as a result of fusion of NBD-PE-labeled F-virosomes with 
F9 cells (or CHO cells) were measured as described above. Percent 
fluorescence dequenching (%FDQ) was calculated as described in 
Section 2.6. Test, F-virosomes in the presence of 1 mM Ca 2+ and 
1 mM Mg2+; Test,Azide, F-virosomes in the presence of 1 mM 
Ca 2+, 1 mM Mg 2+ and 10 mM azide; EDTA, F-virosomes in the 
presence of 50 mM EDTA; Heat, heat-treated F-virosomes in the 
presence of 1 mM Ca 2+ and 1 mM Mg~+; Heat,azide, heat-treated 
F-virosomes in the presence of 1 mM Ca ~+, 1 mM Mg 2+ and 10 
mM azide; CHO cells, F-virosomes incubated with CHO cells in 
the presence of 1 mM Ca 2+ and 1 mM Mg 2+. The values are means 
of duplicate determinations. 
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50 mM EDTA led to complete dissociation (> 98%) of the 
bound virosomes from the surface of F9 cells ('EDTA strip- 
ping') (data not shown). Hence the presence of 50 mM EDTA 
led to complete inhibition of fusion. The fusion activity ob- 
served with heat-treated F-virosomes i  negligible (< 2%) in 
the presence of sodium azide. The little fluorescence de- 
quenching (ca. 5%) observed in the case of heat-treated F-
virosomes may be due to endocytosis of bound non-fusogenic 
virosomes. Negligible fusion activity (< 2%) was obtained 
with CHO cells as target. To provide some indication of the 
reproducibility and variation between experiments, we per- 
formed additional experiments (Fig. 2). Fig. 2 shows that 
the rate of fusion of the F-virosomes with F9 cells was almost 
same in the presence or absence of 10 mM sodium azide in- 
dicating the occurrence of the fusion event at plasma mem- 
brane level. Heat-treated F-virosomes in the presence of 10 
mM sodium azide exhibited no fusion activity. 
3.2. Internalization of [1251]lysozyme into F9 cells delivered 
through F-virosomes : fusion versus endocytosis 
Uptake of [125I]lysozyme by F9 cells at 37°C was examined 
as a function of dose of F-virosomes. Fig. 3 shows a satura- 
tion type curve representing EDTA-resistant cell-associated 
lysozyme. Half of the maximal cell-associated radioactivity 
was obtained with about 200 gg of F-virosomes and this 
was employed in all subsequent experiments. Both F-viro- 
somes and heat-treated F-virosomes were able to bind to F9 
cells to the same extents at 4°C (data not shown). This sug- 
gests that heat denaturation of F protein has no effect on its 
recognition by Le x. However, heat treatment of F protein 
renders it fusion-inactive [10]. The observed internalization 
of lysozyme in the presence of 10 mM azide was apparently 
due to an effective fusion of F-virosomes with F9 cells induced 
by the F protein at plasma membrane l vel. Comparing the 
uptake with F-virosomes (without azide), the internalization 
by fusion mode was found to be about 80% (Fig. 3). However, 
in the case of heat-treated F-virosomes the uptake was negli- 
gible in the presence of 10 mM azide (Fig. 3). 
3.3. Subcellular distribution patterns of the [125I]lysozyme 
delivered by F-virosomes and heat-treated F-virosomes : 
eytosolic delivery of mieroinjeeted marker 
As stated above, about 80% of the total amount of radio- 
activity (EDTA-resistant) associated with the F9 cells was 
retained in the presence of azide, indicating thereby the vital 
role played by the fusion mode in the delivery of lysozyme by 
F-virosomes. Table 1 shows the distribution of radioactivity 
among various organelles of F9 cells. About 75% of the total 
cell-associated radioactivity was recovered in the cytosolic 
fraction using F-virosomes as carrier. Furthermore, the recov- 
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Fig. 2. Kinetics of fusion of F-virosomes with F9 cells in the pre- 
sence and absence of azide. For details about the incubation of 
virosomes and fluorescence measurements, see the legend to Fig. 1. 
II, F-virosomes in the presence of 1 mM Ca 2+ and 1 mM Mg2+; O, 
F-virosomes in the presence of 1 mM Ca 2+, 1 mM Mg 2+ and 10 
mM azide; A, heat-treated F-virosomes in the presence of 1 mM 
Ca 2+, 1 mM Mg 2+ and 10 mM azide. Each value is the mean of 
duplicate determinations. 
10% trichloroacetic a id and specific anti-lysozyme polyclonal 
antiserum. By contrast, 80% of the radioactivity was recov- 
ered in lysosomal/mitochondrial f action with a concomitant 
decrease (84%) in the cytosolic radioactivity in the case of 
heat-treated F-virosomes. These results strongly support he 
fusion-mediated delivery of lysozyme by F-virosomes to F9 
cells. Heat-treated F-virosomes being non-fusogenic are likely 
to be taken up by endocytosis leading to their accumulation 
and subsequent degradation i lysosomes. 
4. Discussion 
The present study demonstrates the potential of F-viro- 
somes in the fusion-mediated transfer of entrapped aqueous 
markers to the cytosol of F9 cells following the corresponding 
mixing of the two apposing bilayer membranes. F, the only 
glycoprotein of these virosomes, contains complex type sugar 
chains, viz. Gal~l ~4(Fuca l  ~ 3)GlcNAc residues in their 
outer chain moieties [7]. This is known as the Le x determinant 
which can interact specifically with Le x moieties present on 
the F9 cells [1]. As a result of this specific attachment, the F- 
Table 1 
Distribution pattern of microinjected [125I]lysozyme over subcellular f actions of F9 cells 
Virosomes % Recovery of radioactivity 
Nuclear Lysosomal/mitochondrial Cytosolic Membrane 
F-Virosomes 9.6 12.4 75.1 2.1 
Heat-treated F-virosomes 3.9 80.1 12.5 4.3 
F9 cells (2× 10 7) were incubated with F-virosomes or heat-treated F-virosomes (2 mg of F protein) in DPBS containing 1mM Ca 2+ and 1 mM 
Mg 2+ for 40 min at 4°C followed by washing and further incubation for 30 rain at 37°C. The cells were EDTA stripped and cell fractionation 
carried out. [125I]Lysozyme associated with each fraction was analyzed as described inSection 2. Total radioactivity associated with F9 cells is set at 
100%. Each value is the mean of three independent determinations. 
20 M. Kumar, D.P. Sarkar/FEBS Letters 391 (1996) 17-20 
__..__ Ca2+,Mg 2÷ 
- -e - -  10mM Na Azide 
50 - -A - -  Heat, Azide 
- / 
~ 40 
~ e  / / ' -  
30 / / 
i 2 /  
.o / /  
. , °  / /  
/ • 
0 -~ __A- -A - - - - - - - - ' I '  ~ J i 
100 200 300 400 500 600 
F-MIROSOME8 (p.g F prote in)  
Fig. 3. dose-dependent i ternalization f [1251]lysozyme into F9 ceils 
delivered through F-virosomes. Different amounts of F-virosomes or 
heat-treated F-virosomes (in terms of F protein) were incubated 
with F9 cells (2×106) in DPBS (containing 1 mM Ca ~+, 1 mM 
Mg2+; or containing 1 mM Ca 2+, 1 mM Mg 2+ and 10 mM azide) 
at 4°C for 40 min followed by washing in respective buffer and 
further incubation for 30 min at 37°C. [125I]Lysozyme associated 
with the cells was determined after EDTA stripping as described in 
Section 3.1. I ,  F-virosomes in the presence of 1 mM Ca 2+ and 
1 mM Mg2+; e, F-virosomes in the presence of 1 mM Ca 2+, 1 mM 
Mg 2+ and 10 mM azide; A, heat-treated F-virosomes in the pres- 
ence of 1 mM Ca 2+, 1 mM Mg 2+ and 10 mM azide. Each point is 
the mean of two independent determinations. 
virosomes were found to fuse with F9 cell membrane as 
judged by both lipid mixing and aqueous connection assays. 
The report presented here emphasizes (for the first time) the 
fact that the F protein can be used both as a ligand and as a 
fusogen for cytosolic delivery of virosomal contents using Le x- 
Le x interaction. Such interactions have been extensively char- 
acterized in last few years [1,2]. Involvement of Le x of F 
protein in the fusion of virosome-F9 cell membrane is inferred 
from its observed sensitivity to 50 mM EDTA (Fig. 1) which 
is known to totally abolish the LeX-Le x interaction [2]. More- 
over, incubation of F-virosomes with a LeX-deficient cell line 
(CHO cells) does not lead to any significant membrane fusion 
(Fig. 1), as observed earlier [10]. Plasma membrane level fu- 
sion of F9 cells with F-virosomes was ascertained from the 
inability of azide to inhibit this process. Heat treatment of F- 
virosomes is known to completely abolish the fusogenicity of 
F protein [8-10]. Very low dequenching of NBD-PE fluores- 
cence of heat-treated F-virosomes with and without the pres- 
ence of azide reflects the specificity of this fusion assay (Fig. 
1). It is interesting to note that the presence of azide during 
fusion does not alter the initial rate of dequenching and heat- 
treated virosomes showed negligible fusion activity in the 
presence of azide (Fig. 2). The most convincing evidence in 
support of cytosolic delivery mediated by F-virosomes 
through LeX-Le × interaction is presented in Fig. 3 and Table 
1. The net internalization (after EDTA stripping) of 
[12"~I]lysozyme into F9 cells as a result of membrane fusion 
appeared to be saturated at a ratio of 400 ~g F protein to 
2 × 106 cells. This can be explained by the limited availability 
of Le x moieties on the F9 cell surface. No significant inter- 
ference by azide on the amount of internalized radioactivity 
further ensures the fusion-mediated delivery process. More- 
over, the radioactivity associated with internalized 
[125I]lysozyme could be mostly recovered (>98%) in 
trichloroacetic acid-insoluble fractions and immunoprecipi- 
tates proving thereby the integrity of delivered lysozyme as 
a result of fusion-mediated process. The studies on subcellular 
localization of intact [125I]lysozyme demonstrates about 75% 
of the radioactivity (EDTA-resistant) to be associated with 
the cytosolic fractions (Table 1). This is in contrast o heat- 
treated F-virosomes where most of the radioactivity (> 80%) 
is retained in lysosomal/mitochondrial fr ction. This provides 
substantive proof to the fusion-mediated cytosolic delivery. 
LeX-terminated glycosphingolipids and glycoproteins are 
highly expressed in a variety of human cancers [17-19]. F- 
virosomes by virtue of LeX-Le x interaction may find their 
use as a potent carrier of cytosol active anticancer drugs. 
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